GMO Financial Holdings, Inc.
Notice Regarding the Date of the Annual General Meeting of Shareholders, Partial Amendment of the Articles of Incorporation, and Appointment of Director Candidates
The annual general meeting of shareholders will be held virtually only on March 19, 2026. The total number of authorized shares will be reduced from 187,500,000 shares to 150,000,000 shares due to a partial amendment of the Articles of Incorporation. Seven directors are scheduled to be appointed.
Key Figures
- Total Number of Authorized Shares: 150,000,000 shares (reduced from 187,500,000 shares)
- Date of Annual General Meeting: 2026-03-19
- Number of Director Candidates: 7 (decreased from previous 8)
AI要約
Schedule of the Annual General Meeting and Overview of the Articles Amendment
GMO Financial Holdings, Inc. plans to hold its Annual General Meeting of Shareholders for the fiscal year ending December 2025 virtually only on March 19, 2026. Through a partial amendment of the Articles of Incorporation, the total number of authorized shares will be reduced from 187,500,000 shares to 150,000,000 shares. This measure aims to secure flexibility in capital policy while considering existing shareholders’ interests, responding to medium- to long-term business area expansion and diversification.
Appointment of Director Candidates and Committee Composition
Following the conclusion of the Annual General Meeting, the number of directors will be reduced from 8 to 7 due to term expiration and appointments. All director candidates are incumbents, including Chairman and Representative Executive Officer Hideyuki Takashima and Executive Officer Itsuki Yamamoto. The chairpersons and members of the Nomination Committee, Audit Committee, and Compensation Committee are listed, with several outside directors and independent officers participating.
